Correction to: EP2/EP4 targeting prevents tumor-derived PGE2-mediated immunosuppression in cDC2s on 8 de November de 2024 at 11:00

13 de November de 2024 by

Spread the love

J Leukoc Biol. 2024 Nov 8:qiae213. doi: 10.1093/jleuko/qiae213. Online ahead of print.

NO ABSTRACT